Oscar Health (NYSE:OSCR) Insider Adam Mcananey Sells 9,859 Shares of Stock

Oscar Health, Inc. (NYSE:OSCR) insider Adam Mcananey sold 9,859 shares of the business’s stock in a transaction that occurred on Tuesday, June 2nd. The shares were sold at an average price of $21.94, for a total value of $216,306.46. Following the completion of the transaction, the insider directly owned 218,096 shares of the company’s stock, valued at $4,785,026.24. The trade was a 4.32% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Oscar Health Trading Up 14.8%

Shares of NYSE:OSCR opened at $23.54 on Friday. Oscar Health, Inc. has a 12-month low of $10.69 and a 12-month high of $25.58. The company has a market capitalization of $7.10 billion, a PE ratio of -39.90, a PEG ratio of 1.43 and a beta of 2.37. The business has a 50 day moving average of $18.15 and a two-hundred day moving average of $16.00. The company has a current ratio of 1.11, a quick ratio of 1.11 and a debt-to-equity ratio of 0.26.

Oscar Health (NYSE:OSCR) last announced its quarterly earnings results on Wednesday, May 6th. The company reported $2.07 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.11 by $0.96. Oscar Health had a negative return on equity of 3.26% and a negative net margin of 0.30%.The company had revenue of $4.65 billion during the quarter, compared to the consensus estimate of $4.90 billion. During the same period in the previous year, the company posted $0.92 earnings per share. Oscar Health’s revenue for the quarter was up 52.6% on a year-over-year basis. As a group, analysts forecast that Oscar Health, Inc. will post 0.47 EPS for the current year.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in the company. Vanguard Group Inc. raised its stake in Oscar Health by 2.7% in the 4th quarter. Vanguard Group Inc. now owns 20,701,250 shares of the company’s stock valued at $297,477,000 after purchasing an additional 540,851 shares during the last quarter. T. Rowe Price Investment Management Inc. raised its stake in Oscar Health by 11.0% in the 4th quarter. T. Rowe Price Investment Management Inc. now owns 9,217,816 shares of the company’s stock valued at $132,461,000 after purchasing an additional 910,320 shares during the last quarter. Morgan Stanley raised its stake in Oscar Health by 42.8% in the 4th quarter. Morgan Stanley now owns 6,814,046 shares of the company’s stock valued at $97,918,000 after purchasing an additional 2,043,758 shares during the last quarter. Thrive Capital Management LLC raised its stake in Oscar Health by 33.4% in the 4th quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company’s stock valued at $85,258,000 after purchasing an additional 1,588,395 shares during the last quarter. Finally, BIT Capital GmbH raised its stake in Oscar Health by 545.0% in the 4th quarter. BIT Capital GmbH now owns 6,186,267 shares of the company’s stock valued at $88,897,000 after purchasing an additional 5,227,152 shares during the last quarter. 75.70% of the stock is owned by institutional investors and hedge funds.

Trending Headlines about Oscar Health

Here are the key news stories impacting Oscar Health this week:

• Positive Sentiment: Wells Fargo upgraded Oscar Health from “strong sell” to “hold”, suggesting the worst of the downside may be behind the stock even though the new $20 target still sits below the current share price. Zacks.com
• Positive Sentiment: A news item that Oscar Health co-founder is shifting into an advisory leadership role appears to be an internal transition rather than a disruptive change, which may be viewed as manageable by investors. Oscar Health Co-Founder Shifts to Advisory Leadership Role
• Neutral Sentiment: Oscar Health reported strong first-quarter EPS of $2.07, beating estimates by a wide margin, though revenue came in below expectations. The earnings beat supports the company’s fundamentals, but the softer revenue print limits the upside reaction.
• Neutral Sentiment: Multiple insiders, including CFO Richard Scott Blackley, Janet Liang, Adam Mcananey, Director Mario Schlosser, and CAO Victoria Baltrus, sold shares under pre-arranged 10b5-1 plans to cover tax withholding on vested equity awards. Because these were scheduled transactions, they are less alarming than discretionary selling, but the cluster of sales can still pressure sentiment.
• Negative Sentiment: The most notable insider sale was by Director Mario Schlosser, who sold 34,120 shares, adding to the perception that leadership is reducing exposure even if the trade was pre-planned.

Analysts Set New Price Targets

A number of research analysts have issued reports on the company. UBS Group boosted their price target on Oscar Health from $15.00 to $20.00 and gave the company a “neutral” rating in a report on Thursday, May 7th. Jefferies Financial Group raised Oscar Health from an “underperform” rating to a “hold” rating and upped their target price for the stock from $10.00 to $16.00 in a research note on Monday, April 20th. Raymond James Financial raised Oscar Health from a “market perform” rating to an “outperform” rating and set a $18.00 target price for the company in a research note on Thursday, February 12th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Oscar Health in a research note on Tuesday, April 21st. Finally, Zacks Research raised Oscar Health from a “hold” rating to a “strong-buy” rating in a research note on Thursday, May 7th. One equities research analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $20.22.

About Oscar Health

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.